1. Home
  2. CYTK vs PAYC Comparison

CYTK vs PAYC Comparison

Compare CYTK & PAYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

N/A

Current Price

$59.89

Market Cap

7.6B

Sector

Health Care

ML Signal

N/A

Logo Paycom Software Inc.

PAYC

Paycom Software Inc.

N/A

Current Price

$126.82

Market Cap

8.9B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CYTK
PAYC
Founded
1997
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
8.9B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
CYTK
PAYC
Price
$59.89
$126.82
Analyst Decision
Strong Buy
Buy
Analyst Count
18
15
Target Price
$87.56
$170.71
AVG Volume (30 Days)
1.7M
2.2M
Earning Date
05-25-2026
05-13-2026
Dividend Yield
N/A
1.15%
EPS Growth
N/A
N/A
EPS
N/A
8.08
Revenue
$13,368,000.00
$433,047,000.00
Revenue This Year
$9.79
$8.79
Revenue Next Year
$302.66
$7.44
P/E Ratio
N/A
$16.12
Revenue Growth
N/A
N/A
52 Week Low
$29.31
$104.90
52 Week High
$70.98
$267.76

Technical Indicators

Market Signals
Indicator
CYTK
PAYC
Relative Strength Index (RSI) 40.30 44.60
Support Level $59.25 $112.93
Resistance Level $65.93 $159.30
Average True Range (ATR) 2.65 5.40
MACD -0.32 1.33
Stochastic Oscillator 3.98 55.26

Price Performance

Historical Comparison
CYTK
PAYC

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About PAYC Paycom Software Inc.

Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.

Share on Social Networks: